ABBOTT LABS: Bayer’s Humira(R) Patent Suits Settled in 2Q11

Patent infringement cases filed by Bayer Healthcare LLC against Abbott Laboratories relating to Humira(R} were settled during the second quarter of 2011.

In its 2010 Form 10-K, Abbott reported that lawsuits…

HOLOGIC INC: Defending Jeffrey Schwindt Patent Suit

Hologic Inc. is defending itself against a patent suit filed by Jeffrey Schwindt.

On March 22, 2011, Jeffrey Schwindt filed suit against Hologic and its subsidiary, Suros Surgical Systems, Inc. in…

HOLOGIC INC: Smith & Nephew Patent Infringement Suit Ongoing

A patent infringement suit filed by Smith & Nephew Inc. against Hologic Inc. is ongoing.

On July 16, 2010 Smith & Nephew filed suit against Interlace, which the Company acquired on…

CENTOCOR INC: Abbott’s Simponi(R) Patent Suit Remains Pending

Abbott Laboratories’ patent infringement suit against Centocor Inc. relating to Simponi(R) is pending.

Abbott is seeking to enforce certain patent rights that cover the use of fully human anti-TNF alpha antibodies…

HOLOGIC INC: Has Patent Settlement Agreement With Ethicon

Two lawsuits between Hologic, Inc., and Ethicon Endo-Surgery, Inc., alleging infringement of biopsy systems patents were settled on February 17, 2010.

On October 5, 2007, Ethicon, a Johnson & Johnson operating…

HOLOGIC INC: Conceptus Patent Suit Remains Pending in California

Conceptus, Inc.’s patent infringement suit against Hologic Inc. remains pending.

On May 22, 2009, Conceptus filed suit in the United States District Court for the Northern District of California seeking a…

GENZYME CORP: ‘775 Patent Dispute with Impax Remains Ongoing

Genzyme Corporation remains in dispute with Impax Laboratories, Inc. over U.S. Patent No. 5,667,775, which expires in 2014.

The Company received notice in 2009, from Impax that it had submitted to…

CANDELA CORP: Cardiofocus Patent Suit Stayed Pending PTO Re-exam

Cardiofocus, Inc.’s patent infringement suit against Candela Corporation remains stayed pending the U.S. Patent & Trademark Office’s re-examination proceedings.

On Feb. 19, 2008, Cardiofocus filed suit against the Company and eight…

CANDELA CORP: Palomar’s Bid to Lift Stay in Patent Suit Pending

The U.S. District Court for the District of Massachusetts has yet to rule on Palomar Medical Technologies, Inc.’s motion to lift the stay in its patent infringement action against Candela…

CANDELA CORP: USPTO’s ‘222 Patent Re-examination Remains Ongoing

The U.S. Patent and Trademark Office’s re-examination of Candela Corporation’s U.S. Patent No. 6,743,222 remains ongoing.

On Aug. 10, 2006, the Company filed suit against Palomar Medical Technologies, Inc., in the…

Page 1 of 512345»